BeOne Medicines Ltd. (SHA:688235)

BeOne Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,516	2,627	3,172	3,870	4,376	1,382
Short-Term Investments	-	-	-	665.25	2,245	3,269
Cash & Short-Term Investments	2,516	2,627	3,172	4,535	6,621	4,651
Cash Growth	-9.92%	-17.16%	-30.06%	-31.50%	42.36%	373.24%
Accounts Receivable	717.24	676.28	358.03	173.17	483.11	60.4
Other Receivables	28.74	32.83	37.86	25.82	17.06	19.27
Receivables	745.98	709.11	395.89	198.98	500.18	79.67
Inventory	494.66	494.99	416.12	282.35	242.63	89.29
Prepaid Expenses	46.28	49.37	88.26	83.09	138.81	57.74
Restricted Cash	11.33	9.31	11.47	0.2	0.33	0.31
Other Current Assets	81.83	101.41	119.88	107.65	111.32	83.01
Total Current Assets	3,896	3,992	4,203	5,207	7,614	4,961
Property, Plant & Equipment	1,745	1,718	1,419	955.91	705.04	448.27
Long-Term Investments	121.14	128.93	89.64	91.78	100.79	49.34
Goodwill	-	-	-	-	0.11	0.11
Other Intangible Assets	50.14	51.1	57.14	40.62	46.68	5
Long-Term Deferred Tax Assets	-	-	-	-	-	65.96
Other Long-Term Assets	28.75	31.56	35.72	83.91	69.03	71.39
Total Assets	5,842	5,921	5,805	6,379	8,536	5,601
Accounts Payable	364.5	405	315.11	294.78	262.4	231.96
Accrued Expenses	627.04	780.48	624.92	480.1	534.33	389.75
Short-Term Debt	725.61	816.95	659.79	314.83	424.74	334.71
Current Portion of Long-Term Debt	37.87	34.58	28.58	14.14	2.82	0.31
Current Portion of Leases	18.3	17.58	21.95	24.04	21.93	13.9
Current Income Taxes Payable	34.14	25.93	22.95	25.19	21.4	20.38
Current Unearned Revenue	-	-	-	213.86	187.41	-
Other Current Liabilities	176.27	134.39	136.82	101.59	144.53	84.2
Total Current Liabilities	1,984	2,215	1,810	1,469	1,600	1,075
Long-Term Debt	160.16	166.48	197.62	209.15	202.11	183.64
Long-Term Leases	54.9	44.28	22.25	34.52	43.04	29.42
Long-Term Unearned Revenue	29.83	30.32	34.2	80.2	266.64	49.14
Long-Term Deferred Tax Liabilities	43.11	42.01	16.49	16	14.17	10.79
Other Long-Term Liabilities	53.97	74.29	172.27	179.78	269.63	375.22
Total Liabilities	2,342	2,589	2,268	1,996	2,403	1,732
Common Stock	0.14	0.14	0.14	0.14	0.13	0.12
Additional Paid-In Capital	12,247	12,088	11,599	11,541	11,191	7,415
Retained Earnings	-8,606	-8,607	-7,962	-7,080	-5,077	-3,553
Comprehensive Income & Other	-142.32	-148.99	-99.45	-77.42	17.95	6.94
Total Common Equity	3,500	3,332	3,537	4,383	6,133	3,869
Shareholders' Equity	3,500	3,332	3,537	4,383	6,133	3,869
Total Liabilities & Equity	5,842	5,921	5,805	6,379	8,536	5,601
Total Debt	996.83	1,080	930.19	596.68	694.64	561.96
Net Cash (Debt)	1,520	1,548	2,242	3,938	5,926	4,089
Net Cash Growth	-12.18%	-30.96%	-43.08%	-33.54%	44.94%	479.63%
Net Cash Per Share	14.34	14.70	21.47	38.19	63.87	48.98
Filing Date Shares Outstanding	107.95	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	107.94	106.72	104.58	104.32	102.68	91.6
Working Capital	1,913	1,777	2,393	3,739	6,014	3,885
Book Value Per Share	32.42	31.22	33.82	42.02	59.73	42.24
Tangible Book Value	3,449	3,281	3,480	4,343	6,086	3,864
Tangible Book Value Per Share	31.95	30.75	33.28	41.63	59.27	42.18
Land	65.49	65.49	65.49	65.49	65.49	-
Buildings	703.58	607.86	231.66	222.45	144.08	111.53
Machinery	501.98	485.14	392.21	334.59	237.79	175.31
Construction In Progress	589.99	654.02	740.62	293.63	186.84	85.78
Leasehold Improvements	63.13	64.68	60.12	53.79	50.29	37.64

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.